niclosamide has been researched along with Disease Exacerbation in 5 studies
Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Metastasis formation in colon cancer severely reduces the survival rate in patients." | 1.37 | Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer. ( Fichtner, I; Kobelt, D; Lemm, M; Sack, U; Schlag, PM; Scudiero, D; Selby, M; Shoemaker, RH; Stein, U; Walther, W, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yuquan, B | 1 |
| Hexiao, T | 1 |
| Laiyi, W | 1 |
| Gaofeng, P | 1 |
| Xuefeng, Z | 1 |
| Ming, X | 1 |
| Yanhong, W | 1 |
| Li, Z | 1 |
| Jinping, Z | 1 |
| King, ML | 1 |
| Lindberg, ME | 1 |
| Stodden, GR | 1 |
| Okuda, H | 1 |
| Ebers, SD | 1 |
| Johnson, A | 1 |
| Montag, A | 1 |
| Lengyel, E | 1 |
| MacLean Ii, JA | 1 |
| Hayashi, K | 1 |
| Suliman, MA | 1 |
| Zhang, Z | 1 |
| Na, H | 1 |
| Ribeiro, AL | 1 |
| Zhang, Y | 1 |
| Niang, B | 1 |
| Hamid, AS | 1 |
| Zhang, H | 1 |
| Xu, L | 1 |
| Zuo, Y | 1 |
| Helfman, DM | 1 |
| Sack, U | 1 |
| Walther, W | 1 |
| Scudiero, D | 1 |
| Selby, M | 1 |
| Kobelt, D | 1 |
| Lemm, M | 1 |
| Fichtner, I | 1 |
| Schlag, PM | 1 |
| Shoemaker, RH | 1 |
| Stein, U | 1 |
5 other studies available for niclosamide and Disease Exacerbation
| Article | Year |
|---|---|
Interaction between epidermal growth factor receptor and interleukin-6 receptor in NSCLC progression.
Topics: A549 Cells; Apoptosis; Carcinoma, Non-Small-Cell Lung; Cell Proliferation; Disease Progression; ErbB | 2019 |
WNT7A/β-catenin signaling induces FGF1 and influences sensitivity to niclosamide in ovarian cancer.
Topics: Animals; beta Catenin; Cell Proliferation; Cells, Cultured; Disease Progression; Drug Resistance, Ne | 2015 |
Niclosamide inhibits colon cancer progression through downregulation of the Notch pathway and upregulation of the tumor suppressor miR-200 family.
Topics: Antinematodal Agents; Apoptosis; Blotting, Western; Cell Line, Tumor; Cell Movement; Cell Proliferat | 2016 |
Niclosamide: an established antihelminthic drug as a potential therapy against S100A4-mediated metastatic colon tumors.
Topics: Animals; Anthelmintics; Antineoplastic Agents; beta Catenin; Biomarkers, Tumor; Cell Line, Tumor; Ce | 2011 |
Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
Topics: Animals; Anthelmintics; Antineoplastic Agents; beta Catenin; Biomarkers, Tumor; Cell Line, Tumor; Ce | 2011 |